Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center

Biologics are important treatment options for psoriasis; however, direct comparison of their efficacy, safety, and drug survival is insufficient in clinical practice. This retrospective single-center study aimed to compare the efficacy, safety, and drug survival of three commonly used psoriasis biol...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Seung-Won, Lim, Sung Ha, Jeon, Jae Joon, Heo, Yeon-Woo, Choi, Mi Soo, Hong, Seung-Phil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139155/
https://www.ncbi.nlm.nih.gov/pubmed/35625795
http://dx.doi.org/10.3390/biomedicines10051058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139155/
https://www.ncbi.nlm.nih.gov/pubmed/35625795
http://dx.doi.org/10.3390/biomedicines10051058

Ejemplares similares